| |
---|
| Detailed Price Information Link |
BACTERIA | How to read the following data (Example) |
Name: | Actinomyces israelii (Kruse 1896) Lachner-Sandoval 1898 emend. Nouioui et al. 2018 |
DSM No.: | 43323 dsm-43323 dsm43323 dsm 43323 Actinomyces israelii |
Strain designation: | WVU 339 |
Serovar: | 1 |
Isolated from: | human actinomycosis |
Country: | country of origin unknown |
Date of sampling: | before 22.08.1990 |
Nagoya Protocol Restrictions: | There are NO known Nagoya Protocol restrictions for this strain. |
History: | <- M.A. Gerencser, WVU 339 <- J.W. Porteous (Wills strain) |
Cultivation conditions: | Medium 216 , anaerobic, 37°C Medium/media recipe(s) required for preparing 216: - Medium 215
Complete DSMZ Media List |
Summary and additional information: | <- M.A. Gerencser, WVU 339 <- J.W. Porteous (Wills strain). Human actinomycosis. Serovar 1. (1573). (Medium 216, 37°C, anaerobic) |
Literature: | 1573 |
Risk group: | 2 (classification according to German TRBA) |
Restrictions: | Act dealing with the prevention & control of infectious diseases in man (Infektionsschutzgesetz), Category A1
|
Supplied as: | Delivery form | | Prices | | Freeze Dried | | 100,- € | Active culture on request | | 240,- € | DNA | | 150,- € | | Price Category for this culture: 1 |
Freight and handling charges will be added. See price list. Note: Freight charges for Risk Group 2 microorganisms will apply. |
Other cultures: | All DSMZ cultures of the species |
| Print data sheet |